Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Integrin Antagonists 27 is a small molecule integrin αvβ3 antagonist. It has a binding affinity of 18 nM and as a novel anticancer agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 8-10 weeks | $ 198.00 | |
5 mg | 8-10 weeks | $ 347.00 | |
25 mg | 8-10 weeks | $ 1,140.00 | |
50 mg | 8-10 weeks | $ 1,490.00 | |
100 mg | 8-10 weeks | $ 1,990.00 | |
1 mL * 10 mM (in DMSO) | 8-10 weeks | $ 382.00 |
Description | Integrin Antagonists 27 is a small molecule integrin αvβ3 antagonist. It has a binding affinity of 18 nM and as a novel anticancer agent. |
In vitro | Integrin Antagonists 27 is treated with a panel of cancer cell lines. Which include breast cancer cell line MDA-MB-435, breast cancer cell lines MCF-7, mouse fibroblast NIH3T3, ovarian cancer cell line HEY, lung cancer cell line NCI-H1975. It has an IC50 of >20 uM. |
Molecular Weight | 444.44 |
Formula | C24H20N4O5 |
CAS No. | 593274-97-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (225.00 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Integrin Antagonists 27 593274-97-6 Others inhibitor inhibit